A Minimally Invasive Platform to Target, Image, and Treat Head and Neck Cancer

用于定位、成像和治疗头颈癌的微创平台

• 批准号: 9084006
• 负责人: Hadiyah-Nicole Green
• 金额: --
• 依托单位: BIRMINGHAM VA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-05-01 至 2021-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9084006
• 关键词: Adjuvant Therapy; Adverse effects; Antibodies; Antibody Specificity; Antibody Therapy; Binding; Cell Death; Clinical; Data; Engineering; Epidermal Growth Factor Receptor; Fluorescence; Fluorescent Dyes; Gold; Head and Neck Cancer; Heating; Human; Image; In Vitro; Intravenous; Kinetics; Knowledge; Label; Lasers; Life; Longevity; Malignant Neoplasms; Mediating; Metastatic/Recurrent; Methods; Modality; Modeling; Mus; Palliative Care; Palpable; Patients; Performance; Permeability; Quality of life; Recurrence; Reporting; Resistance; Specificity; Staging; Techniques; Testing; Therapeutic; Time; Tissue Sample; Translating; Translations; Treatment Efficacy; Treatment Protocols; Tumor Volume; United States Department of Veterans Affairs; Veterans; Xenograft Model; absorption; antibody conjugate; base; cancer cell; cancer therapy; cell killing; cost; experience; fluorescence imaging; human tissue; improved; in vivo; in vivo Model; killings; minimally invasive; nanoparticle; nanorod; nanotherapy; neoplastic cell; novel; outcome forecast; patient population; public health relevance; response; standard of care; targeted delivery; targeted imaging; targeted treatment; tumor